Home › Funds › Point72 Asset Management › FDMT
Point72 Asset Management position in FDMT
4D MOLECULAR THERAPEUTICS IN · Health Care
Latest position (Q4 2025)1.54M sh
Reported value held$11.55M
Portfolio Weight0.01%
First reportedQ3 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 299.00K | $2.40M | New |
| Q4 2022 | 139.30K | $3.09M | Reduce |
| Q1 2023 | 208.90K | $3.59M | Add |
| Q2 2023 | 370.89K | $6.70M | Add |
| Q3 2023 | 453.38K | $5.77M | Add |
| Q4 2023 | 416.02K | $8.43M | Reduce |
| Q3 2024 | 15.34K | $165.84K | New |
| Q4 2025 | 1.54M | $11.55M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FDMT
- BlackRock Inc 4.55M sh · $60.46M · Q2 2026
- Goldman Sachs Group 4.26M sh · $56.64M · Q2 2026
- Janus Henderson Group 5.25M sh · $48.87M · Q1 2026
- Vanguard Group 3.09M sh · $23.20M · Q4 2025
- Geode Capital Management 1.13M sh · $15.01M · Q2 2026
- Bank of America Corp 1.12M sh · $14.90M · Q2 2026
- Citadel Advisors 901.20K sh · $11.99M · Q2 2026
- Deutsche Bank AG 710.94K sh · $9.46M · Q2 2026
- Renaissance Technologies 614.57K sh · $8.17M · Q2 2026
- Northern Trust Corp 562.93K sh · $7.49M · Q2 2026
- Morgan Stanley 503.02K sh · $6.69M · Q2 2026
- JPMorgan Chase & Co 402.14K sh · $5.18M · Q2 2026